About the Author
Dr. Vijai Singh is an Associate Professor in the Department of Biosciences, School of Science at Indrashil University, Mehsana, Gujarat, India. Prior to this, Dr. Singh was a postdoctoral fellow at Institute of Systems and Synthetic Biology, France and School of Energy and Chemical Engineering at Ulsan National Institute of Science and Technology, South Korea. Dr. Singh has served as an Assistant Professor in the Department of Biotechnology at Invertis University, India and School of Biological Sciences and Biotechnology, Institute of Advanced Research, India. Dr Singh received his Ph.D. in Biotechnology from Dr. APJ Abdul Kalam Technical University / National Bureau of Fish Genetic Resources, Lucknow, India with a research focus on the development of molecular and immunoassay for Aeromonas hydrophila. Dr. Singh has designed and characterized a number of synthetic oscillators, gene networks, lycopene pathway, MAGE and CRISPR-Cas9 system in Escherichia coli. Currently, Dr. Singh's laboratory focuses on the construction of a novel biosynthetic pathway for the production of pigments, chemicals, and fuels. Additionally, Dr. Singh's laboratory works on developing CRISPR-based platform for disease diagnosis and eradication of MDR pathogens. Dr. Singh has published 72 articles in the peer-reviewed journals, 19 chapters, and 1 book. Dr. Singh serves as a member of the editorial board and reviewer of a number of peer-reviewed journals. Prof. Pawan K. Dhar is the Dean, School of Biotechnology, Jawaharlal Nehru University, New Delhi and heads an active synthetic biology group. Prior to this he held scientific positions at RIKEN Institute, Keio University and Kyoto University (Japan) Bioinformatics Institute, (Singapore) and Manipal University (India). Prof. Dhar received his Ph.D. in 1993 from Banaras Hindu University (Varanasi) for his work on Human Genetics. Prof Dhar's lab holds specialization in making functional proteins from non-expressing DNA sequences leading to the development of a potentially groundbreaking drug discovery platform. Prof. Dhar serves in the external board of referees for European Science Foundation and Indian Government science funding agencies.